Low-Dose Colchicine May Help Stabilize Coronary Plaques
The LoDoCo2 trial found a reduced cardiovascular risk with low-dose colchicine in patients with chronic coronary disease. In this substudy, attenuation of pericoronary adipose tissue did not differ between patients receiving low-dose colchicine and those receiving placebo; however, people taking colchicine had a higher volume of dense calcified plaque, indicating improved plaque stability.
METHODOLOGY:
Elevated attenuation of pericoronary adipose tissue and a high burden of noncalcified plaque have been linked to adverse coronary outcomes caused by plaque rupture and instability; statins mitigate these risks by promoting plaque calcification.
This cross-sectional substudy of the LoDoCo2 trial investigated if treatment with low-dose colchicine would attenuate coronary inflammation, as evidenced by less attenuation of pericoronary adipose tissue in 151 patients with chronic coronary disease (mean age, 64.4 years; 14% women).
Patients were randomly assigned to receive either low-dose colchicine (0.5 mg once daily; n = 79) or placebo (n = 72).
All patients had previously undergone coronary stenting at enrollment and were on antiplatelet and/or anticoagulant therapy; high-intensity statin therapy consisted of 40 mg and 80 mg doses of atorvastatin.
After a median treatment duration of 28 months, coronary CT angiography (CCTA) was performed to evaluate the attenuation of pericoronary adipose tissue in the proximal segments of epicardial coronary arteries and to assess plaque characteristics.
TAKEAWAY:
Median attenuation did not differ significantly between the patients receiving colchicine and those receiving placebo.
Compared with patients receiving placebo, those receiving colchicine showed a higher calcified plaque burden (adjusted difference, 2.4%), higher calcified plaque volume (adjusted difference, 59 mm 3 ), and higher volume of dense calcified plaque (adjusted difference, 61.5 mm 3 ; P < .05 for all).
), and higher volume of dense calcified plaque (adjusted difference, 61.5 mm ; < .05 for all). In patients on low-intensity statin therapy, colchicine treatment was associated with a lower burden of low-attenuation plaque, an effect not observed in those receiving high-intensity statins ( P for interaction = .037).
IN PRACTICE:
Low-dose colchicine was associated with an overall higher volume of calcified plaque, particularly dense calcified plaque, as well as a lower burden of low-attenuation plaque in participants treated
with colchicine and low-intensity statins,' the researchers wrote. 'Although the cross-sectional design of the study limits causal inference, these are features of plaque stability and may partly explain the reduction in risk of cardiovascular events associated with colchicine in patients with chronic coronary disease.'
SOURCE:
This study was led by Aernoud T L Fiolet, MD, PhD, of University Medical Centre Utrecht, Utrecht, the Netherlands. It was published online on May 19, 2025, in Heart .
LIMITATIONS:
The researchers conducted this cross-sectional analysis at the end of treatment, without any baseline or temporal studies. This study had relatively fewer women than the proportion of women with cardiovascular disease in the general population. Additional imaging modalities were not used to confirm the findings from CCTA.
DISCLOSURES:
This study received grants from the Australian National Institutes of Health/National Heart, Lung, and Blood Institute, Withering Stichting Nederland, the Netherlands Heart Foundation, and the Netherlands Organisation for Health Research and Development. One author reported receiving software royalties from Cedars-Sinai Medical Center. Another author reported giving presentations, and three authors reported serving as consultants for pharmaceutical and healthcare companies without receiving any personal fees.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Entrepreneur
43 minutes ago
- Entrepreneur
Estee Lantos Launches Refined Masterclass to Help People Slow Biological Aging by Transforming Stress from Within
Learn how nervous system regulation and optimised, yet not rigid lifestyle practices such as sleep, nourishment, movement can help you feel your best and slow down ageing, beginning June 1st You're reading Entrepreneur United Kingdom, an international franchise of Entrepreneur Media. Estee Lantos, a respected voice in biohacking and holistic wellness, is proud to unveil the revamped version of her "Biohack with Nervous System-first Masterclass – a transformative experience designed to help participants understand the factors that influence their biological age and how they can respond to life with more ease & connection. The masterclass is available online from June 1st and is priced at just £50. This 90-minute pre-recorded training is a powerful entry point into Estee's broader wellness ecosystem, offering education and practical tools to to help people feel better, function optimally, and maintain youthful vitality. Estee Lantos "Our culture teaches us to manage stress after it happens. But what if you could train your body to respond differently in the first place?" says Estee. "The key to longevity isn't just in what you eat or how you sleep—it lies in a holistic approach that begins with how effectively you can guide your nervous system back to safety, and live from a place of ease. Inside the Masterclass: A Step-by-Step Guide to Real Change Participants will learn: The science of stress and how the nervous system responds How to create safety within the body through cues and awareness Lifestyle pillars including sleep and recovery, cycle aligned movement and nourishment, cellular health and some other health optimisation practices that actually nourish you. A softer, more sustainable approach to wellness – focused on connection and community But the masterclass is just the beginning. Estee offers a range of transformational services to support individuals at every stage of their wellness journey. Her practice is built around two other core offerings: Somatic Work Personalized support through 1:1 sessions online or in-person sessions, where clients are guided through TRE (Tension, Stress & Trauma Release Exercise) – a body-based practice to release stored stress and reset the nervous system. Ideal for those needing deeper emotional and physical grounding. The Path: 6-Month Transformational Program Estee's signature, high-touch program that includes personalized biological age testing (in partnership with GlycanAge), customized plans, holistic protocols, and continuous coaching. It's an intimate experience built around accountability, deep change, and long-term vitality. Why It Matters Today, many people assume they are living healthy lives – but when they take a biological age test, they're shocked to discover their body is aging faster than expected. Estee's mission is to close this gap through a gentle, scientific, and highly personalised approach. The masterclass not only educates but empowers people to take back control of their health & longevity. The Refined Masterclass is now live. To learn more and join the experience, visit Estee's website or follow her on Instagram
Health Line
an hour ago
- Health Line
Does Medicare Cover Shoulder Replacement Surgery?
Key takeaways Original Medicare (parts A and B) covers shoulder replacement surgery when a doctor certifies it as medically necessary. Part A covers open surgeries, and Part B covers arthroscopic procedures. To qualify for coverage, you must have a specific diagnosis, such as a degenerative joint disease, post-traumatic arthritis, or rotator cuff injury, along with evidence of chronic pain or disability lasting at least 12 weeks. Out-of-pocket costs include deductibles, coinsurance, and copayments, even with Medicare coverage. In 2025, the deductible for inpatient surgery under Part A is $1,676 per benefit period. Part B has a $257 annual deductible plus a 20% coinsurance on Medicare-approved costs. Your shoulder is a flexible joint that's highly susceptible to injury and wear and tear. A severely damaged shoulder could affect your quality of life. Even so, shoulder replacement surgery is often categorized as elective. Because Medicare doesn't typically cover elective surgeries, you may be concerned that you'll have to live with pain or pay for the surgery out of pocket. But Medicare will, in fact, pay for a portion of the costs if your doctor states that shoulder replacement surgery is medically necessary in your specific case. Is a shoulder replacement covered by Medicare? You might need shoulder replacement surgery to repair your shoulder or to reduce further damage to the joint. Your doctor must certify that your surgery is required to heal or prevent ongoing damage caused by a disease, such as arthritis. This doctor must also be enrolled in and approved by Medicare. Keep in mind that you'll need to meet your deductible and pay your share of coinsurance or copayments. To avoid surprises, it's also a good idea to confirm the details of your coverage with Medicare or your supplemental plan. Here's what's covered under each part of Medicare: Medicare Part A coverage Open surgery is an invasive option that requires a surgeon to make a large incision to repair or replace your shoulder. If your open shoulder replacement is medically necessary, Medicare Part A will cover a portion of the cost. Part A is one part of Original Medicare. Part A will also cover any medications or therapies you receive during your stay at a hospital, skilled nursing facility, or rehabilitation center, but there are limits to how long Medicare will cover a stay at any type of inpatient facility. Medicare Part B coverage Shoulder surgery may also be performed arthroscopically. This minimally invasive procedure is typically performed in a hospital or freestanding clinic on an outpatient basis. If you have an arthroscopic shoulder replacement, your surgeon makes a small incision in your shoulder and places a small camera there. Through another small incision, your surgeon repairs or replaces portions of your shoulder. If your arthroscopic shoulder replacement surgery is medically necessary, Medicare Part B — the other part of Original Medicare — will cover a portion of the cost. Part B also covers these items and services as well, if needed: all of your doctors' appointments before and after surgery physical therapy following surgery, which you'll need no matter what type of procedure you have any durable medical equipment you need after surgery, such as an arm sling Medicare Part C coverage If you have Medicare Part C (Medicare Advantage), your plan will cover all the expenses covered by Original Medicare (parts A and B). Depending on your plan, it may also cover prescription drugs. If you have a Part C plan, it's important to use in-network healthcare professionals and pharmacies to lower your out-of-pocket costs. Medicare Part D coverage Medicare Part D covers any drugs prescribed for you to take after surgery, such as pain medication. It is optional prescription drug coverage offered through Medicare. Each Part D plan includes a formulary. This is a list of medications that the plan covers and the percentage of coverage you can expect. Medigap coverage If you have Original Medicare, you might also have a Medigap plan. Depending on your plan, Medigap may cover some of the remaining out-of-pocket costs for your shoulder replacement surgery. This can include your copays, coinsurance, and deductibles. Medigap typically covers medication copays through Part D. Note, though, that most plans are not allowed to cover the Part B premium. How do you qualify for shoulder replacement? The Centers for Medicare & Medicaid Services (CMS) consider shoulder replacement surgery as medically necessary when you have a diagnosis of various conditions, including degenerative joint diseases like osteoarthritis, post-traumatic arthritis, and rotator cuff injury. To qualify, you'll need to provide medical records showing the diagnosis through imaging. You'll also need to show evidence of living with chronic pain or disability for at least 12 weeks as a result of the condition and a history of other treatments that were unsuccessful. Other situations that may require this procedure include acute fractures or tumor removals. Medicare may ask you to do physical therapy before approving surgery in some cases. Reverse surgery may also be necessary after previous failed procedures. What are the out-of-pocket costs for covered procedures? It may be difficult to estimate your exact out-of-pocket costs before your procedure. Your doctor's billing office should be able to give you a written estimate of what you can expect. This usually includes a range of potential costs based on the services you might require during and immediately after the procedure. Original Medicare costs There are out-of-pocket costs that you can expect, even if you have Medicare. These include: Medicare Part A premium: Most people pay no premium for Part A because they paid Medicare taxes long enough while working. However, if you or your spouse did not work at least 40 quarters of Medicare-covered employment (10 years), you may pay a premium of $285 or $518 in 2025, depending on how long you or your spouse paid Medicare taxes. Inpatient surgery: Your Part A inpatient hospital deductible is $1,676. This covers the first 60 days of Medicare-covered inpatient hospital care in a benefit period. Coinsurance: If you require a longer stay, you will pay a coinsurance amount of $419 daily from day 61 through day 90 in a benefit period and $838 daily for any lifetime reserve days you use. Skilled nursing facility care: If you stay in a skilled nursing facility, your daily coinsurance cost from day 21 through day 100 in a benefit period would be $209.5 per day. Outpatient surgery: For outpatient surgery, you're responsible for meeting your Part B annual deductible of $257, as well as your monthly premium, which is $185 for most people in 2025. Medicare-approved costs: You'll pay 20% of the Medicare-approved cost of the outpatient procedure. Durable medical equipment and physical therapy: You'll also pay 20% of the costs for any durable medical equipment and physical therapy appointments. Medicare Part C costs If you have Medicare Part C, your costs will vary depending on the type of plan you have. Your insurer can give you specific coverage and copay details ahead of time. Typically, you can expect to pay some form of copay. No matter which type of Part C plan you have, it's legally required that your plan cover at least as much as Original Medicare. This includes the costs of inpatient or outpatient surgery. Medicare Part D costs If you have Medicare Part D, your costs will differ based on your plan. You will most likely have some copay costs for any medications prescribed for you. Your plan's formulary and tier system set the costs per drug. Your plan provider can let you know what you will pay for each medication ahead of time. Tip Medicare has a procedure price lookup tool, which could help you determine the cost of an outpatient surgery. To get the most accurate results, ask your doctor for the exact name of the procedure or the code for that type of surgery. Frequently asked questions What is the average cost of shoulder replacement surgery without insurance? According to research from 2018, total shoulder replacement has a mean total out-of-pocket cost of $14,000 to $52,000 per patient. How long does it take for the elderly to recover from shoulder replacement surgery? Generally, Most people can resume gentle daily activities within 2 to 6 weeks after the surgery and more strenuous sports within about 6 months. That said, older adults may take longer to recover.
Medscape
an hour ago
- Medscape
Worm-Inspired Treatments Inch Toward the Clinic
The experiment was a striking attempt to investigate weight control. For 6 weeks, a group of mice gorged on lard-enriched mouse chow, then scientists infected the mice with worms. The worms wriggled beneath the animals' skin, migrated to blood vessels that surround the intestines, and started laying eggs. Bruno Guigas, a molecular biologist at the Leiden University Center for Infectious Diseases in the Netherlands, led this study some years back and the results, he says, were 'quite spectacular.' The mice lost fat and gained less weight overall than mice not exposed to worms. Within a month or so, he recalls, the scientists barely needed their scale to see that the worm-infested mice were leaner than their worm-free counterparts. Infection with worms, it seems, reversed obesity, the researchers reported in 2015. While it's true that worms gobble up food their hosts might otherwise digest, that doesn't seem to be the only mechanism at work here. There's also some intricate biology within the emerging scientific field of immunometabolism. Over the past couple of decades, researchers have recognized that the immune system doesn't just fight infection. It's also intertwined with organs like the liver, the pancreas and fat tissue, and implicated in the progression of obesity and type 2 diabetes. These and other metabolic disorders generate a troublesome immune response — inflammation — that worsens metabolism still further. Metabolic disease, in other words, is inflammatory disease. Scientists have also observed a metabolic influence of worms in people who became naturally infected with the parasites or were purposely seeded with worms in clinical trials. While the physiology isn't fully understood, the worms seem to dampen inflammation, as discussed in the 2024 Annual Review of Nutrition . 'We're never going to cure or treat metabolic disease with worm infections,' says Guigas. They cause unpleasant side effects like nausea, and it would be impractical to dose millions of people with parasites. But worms can be valuable tools for scientists to understand the feedback between inflammation and metabolism. The findings could inspire more traditional, less ick-inducing treatments. The Worms' Good Turns The worms we're talking about are helminths such as flukes and roundworms. While they've largely been eliminated from developed nations, an estimated 1.5 billion people worldwide carry them. They can be dangerous in high numbers, and cause symptoms such as diarrhea and malnutrition in those at high risk, including children and immunocompromised individuals, and during pregnancy. But for most people, infection with a few worms is pretty benign. 'Throughout human evolution, I think, there's been this nice sort of truce,' says Paul Giacomin, an immunologist at James Cook University in Cairns, Australia. As part of that detente, he says, helminths evolved molecules that tell the human immune system, 'I'm not here, don't worry about me.' In turn, people might have evolved to depend a bit on worms to temper inflammation. Today, metabolic disease is a massive global problem, with obesity affecting an estimated 890 million people. Another 580 million have type 2 diabetes, which arises when the hormone insulin, which controls blood sugar levels, is in short supply or the body's cells become insensitive to it. Links between metabolic disease and worm infection emerged from research on human populations. Studies in Australia, Turkey, Brazil, China, India and Indonesia showed that people with metabolic conditions such as diabetes were less likely to have helminth infections, and vice versa. 'This observation is quite strong,' says Ari Molofsky, an immunologist at the University of California, San Francisco. Going a step further, scientists observed what happened when they provided deworming treatments.' The overwhelming majority of the studies showed that deworming worsens your metabolic health,' says Giacomin. Scientists looked to lab mice for additional clues. Molofsky and colleagues, in 2011, reported that when they infected mice on high-fat food with the gut worm Nippostrongylus brasiliensis , the infection improved blood sugar control. Similarly, in Guigas' study, published in 2015, the worms — blood flukes called Schistosoma mansoni — improved not just weight, but also blood sugar processing. And the worms needn't be alive: Even molecules collected from crushed worm eggs improved metabolism. The going hypothesis is that metabolic problems kick off a vicious immunometabolic cycle. First, Guigas says, damaged cells in metabolic organs cry for help, releasing molecular signals that call in immune cells. When the immune cells arrive, they morph into forms that promote a type of inflammation called Th1. Th1 responses are good at combating viruses, but they're the wrong choice here. Th1 can aggravate metabolic problems by impairing insulin manufacture, altering insulin signaling and amplifying insulin resistance. Thus, instead of helping, the immune cells cause further stress in the metabolic tissues. So the tissues call in more immune cells — and the cycle repeats. Worms seem to break the cycle. In great part, that's probably because their 'I'm not here' message causes a different kind of immune response, Th2, that dampens the Th1 reaction and re-normalizes the system. Other mechanisms might also be at work: Worms might reduce appetite; it's known they can alter gut microbes; and Guigas suspects they can also manipulate creatures' metabolisms via non-immune pathways. 'The parasitic worms are real masters at controlling inflammation,' says Giacomin, who coauthored an article on helminths and immunity in the 2021 Annual Review of Immunology . Thus, scientists interested in controlling immunometabolic disease might take cues from these wriggly little metabolic masterminds. In fact, researchers have already tested helminths to control inflammation in autoimmune conditions such as inflammatory bowel disease. The accumulating evidence linking worms to metabolic benefits in animals and people inspired Giacomin and colleagues to conduct a trial of their own. Commencing in 2018, they decided to try the hookworm Necator americanus in 27 obese people who had insulin resistance, putting them at risk for type 2 diabetes. The researchers applied worm larvae in patches on the subjects' arms; after passing through the skin, the worms would travel through the blood stream, to the lungs and then to the small intestine. An additional 13 participants were assigned to placebo patches with Tabasco sauce to mimic the itch of entering worms. N americanus is a common cause of hookworm infections across much of the world. While most cases are asymptomatic, the time when the worms are attaching to the intestinal wall can cause symptoms like nausea and low iron levels, especially if there are a lot of worms. So the main goal was to determine if the treatment was safe, trying doses of 20 or 40 worms. Many subjects suffered short-term unpleasantness such as bloating or diarrhea as they adjusted to their new intestinal tagalongs, but overall, most did fine. After 12 months, the people who got hookworms had lower insulin resistance and reduced fasting blood sugar levels. After two years, those who received 20 worms had lost an average of 11 pounds — though not all individuals lost weight, and some gained. 'It was quite convincing that the worms were having some sort of beneficial effect,' says Giacomin. The subjects were convinced too: When the study was over, the researchers offered deworming, but most participants elected to keep their worms. Giacomin and Guigas hope to identify worm components or invent worm-inspired molecules to produce similar effects without whole parasites. Giacomin cofounded a company, Macrobiome Therapeutics in Cairns, to develop hookworm molecules into treatments. Such medications might be based on the wriggly parasites, but they'd be an easier pill to swallow.
